Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 10-Q, Date: 2013-05-15, XBRL Interactive Financials
Original SEC Filing: Click here

---

Webplus: BSPM/20130515/10-Q/1/000.htm SEC Original: biostar10q033113.htm
FORM 10-Q (Mark One) x March 31, 2013 For the quarterly period ended: Or For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, Maryland 20-8747899 (State or other jurisdiction oforporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China

---

---

Webplus: BSPM/20130515/10-Q/2_EX-31.1/000.htm SEC Original: ex31-1.htm
CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Quarterly 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with

---

---

Webplus: BSPM/20130515/10-Q/3_EX-31.2/000.htm SEC Original: ex31-2.htm
CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Quarterly 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with

---

---

Webplus: BSPM/20130515/10-Q/4_EX-32.1/000.htm SEC Original: ex32-1.htm
CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated.ted: May15, 2013 Ronghua Wang Chief Executive Officer ex32-1.htm 4 EX-32.1

---

---

Webplus: BSPM/20130515/10-Q/5_EX-32.2/000.htm SEC Original: ex32-2.htm
CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated.ted: May15, 2013 Qinghua Liu Interim Chief Financial Officer (principal financial officer) ex32-2.htm 5 EX-32.2

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 10-Q, Date: 2013-05-15, XBRL Interactive FinancialsCIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046